Naurex naurex.com


Naurex is a biopharmaceutical company developing novel modulators of the NMDA receptor to treat challenging diseases of the central nervous system (CNS). The company's first-generation compound, GLYX-13, is in development as adjunctive therapy for patients with difficult-to-treat depression. GLYX-13 has shown rapid-acting and robust antidepressant activity in Phase 2 clinical studies and has been well tolerated with none of the psychotomimetic side effects that limit other drugs and mechanisms t...Show all

Naurex is a biopharmaceutical company developing novel modulators of the NMDA receptor to treat challenging diseases of the central nervous system (CNS). The company's first-generation compound, GLYX-13, is in development as adjunctive therapy for pa...Show all

Company (Acquired)

Phone: 847-871-0377

Fax:

1801 Maple Avenue
Suite 4300
Evanston, 60201
Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Naurex $162.3M Jul 27, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Naurex Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Hydroxamic acid derivatives, preparation and therapeutic uses thereof Mar 01, 2013 Application